Nuvation Bio Inc (NUVB): Take a Look at Glioma Revenue Potential

For this action, the steadfast cited the imaginable of Nuvation Bio’s glioma cause candidate, safusidenib. First, RBC Capital pointed retired that there’s an unmet request successful the glioma market, peculiarly successful the high-grade glioma segment.

According to the firm, Nuvation Bio’s safusidenib could go a first-in-class attraction for high-grade glioma. The steadfast besides sees imaginable for this cause campaigner successful the low-grade glioma marketplace arsenic well. In RBC Capital’s estimates, safusidenib could make arsenic overmuch arsenic $3.4 cardinal successful US income for Nuvation Bio.

Nuvation Bio’s safusidenib is successful Phase 3 study. On February 9, Nuvation Bio provided protocol updates regarding the Phase 3 SIGMA proceedings of Nuvation Bio. The updates included expanding the proceedings pursuing discussions with regulatory agencies, doctors, and advocacy groups, the institution said.

Nuvation Bio added that the protocol updates reflected alignment with US regulators, mentioning imaginable for swift support of safusidenib for patients who severely request a attraction option.

In Q4 2025, Nuvation Bio generated gross of $$41.9 million, surpassing the statement estimation of $38.55 million. It wrapped up the 4th with $529.2 cardinal successful cash, currency equivalents, and marketable securities.

Nuvation Bio Inc (NYSE:NUVB) is an American biopharmaceutical institution founded successful 2018. The institution is focused connected processing crab medicines. It’s focused connected tackling the toughest attraction crab challenges.

While we admit the imaginable of NUVB arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 8 Must-Buy Small Cap Stocks to Buy and 10 Best Medical AI Stocks to Buy Now.

Disclosure: None. Follow Insider Monkey connected Google News.